Their incidence continues to increase due in part to improved treatment and longer survival of AIDS patients.4 '5 Roughly 90 percent of AIDS-related NHLs are of intermediate or high-grade B lymphocytes of either the immunoblastic or small noncleaved type. In the latter, the classic Burkitt's or non-Burkitt's lymphoma may be seen. In contrast, these high-grade types are expected in approximately 10 percent of the usual patients with lymphoma.6'7 When compared with the histologically similar NHLs arising in immunocompetent patients, systemic AIDS-related NHLs display distinctive features, including poor prognosis and frequent involvement of extranodal sites, particularly the gastrointestinal tract, central nervous system, and bone marrow.8 '9 Cardiac abnormalities in HIV-infected individuals are common, occurring in 17 to 64 percent of cases evaluated by noninvasive means and in 31 to 77 percent in postmortem studies.'0 These abnormalities include myocarditis with and without cardiomyopathy, endocarditis, pulmonary hypertension, and arrhythmias. However, NHL involving the heart or pericardium due to lymph-hematogenous spread in HIV patients is a most unusual development. 11, 12 In a study of 90 patients with AIDS who developed lymphoma, only one case involved the pericardium. 13 Details regarding whether NHL was limited to the heart or was widely disseminated at the time of diagnosis were not provided. Non-Hodgkin's lymphoma occurring as a primary cardiac or pericardial tumor in AIDS-related lymphomas is even more rare; most patients with this finding possess diffuse large cell or small noncleaved cell histologic findings.' 146 Clinical presentations vary with FIGURE 2. Computed tomography scan of chest demonstrates bilateral pleural effusions (PLF) and a large pericardial effusion encompassing the heart (H). RLL, right lower lobe; LLL, left lower lobe.
several reports describing intractable congestive heart failure, pericardial effusions, or arrhythmias as sentinel signs of cardiac involvement. The NHL that predominantly involves the heart rarely is detected antemortem and in many cases constitutes the immediate cause of death. In this study, the clinical course of a patient with AIDS and isolated cardiac lymphoma is reported and compared with the clinical courses of patients previously reported in the literature.
CASE REPORT
A 42-year-old white homosexual male developed a purplish plaque on his left arm in March 1989. A punch biopsy of the lesion demonstrated Kaposi's sarcoma (KS) and serologic testing for HIV proved positive. He was treated initially with zidovudine, then switched to didanosine 6 months later when he developed moderate neutropenia. In February 1990, he received external beam radiotherapy for advancing lower extremity KS. He also received intralesionally administered vinblastine and topically applied liquid nitrogen for cosmetically bothersome trunk and arm lesions. At the time of widespread tumor progression 6 months later, he began a regimen consisting of intravenously administered vincristine and vinblastine chemotherapy. In 1991, therapy with subcutaneously administered a-interferon, given three times weekly, was initiated when growth of cutaneous lesions accelerated.
In April 1992, the patient presented with a symptom complex including low-grade fevers and progressive dyspnea of several days in duration. Physical examination disclosed decreased breath sounds at the lung bases, elevated jugular venous distention to the angle of the jaw, decreased heart tones, and hepatomegaly but without peripheral edema or adenopathy. Pertinent laboratory data included the following: hematocrit value, 33 (Fig 1) . A transthoracic two-dimensional echocardiogram displayed a large pericardial effusion with evidence of both right atrial and right ventricular collapse consistent with cardiac tamponade. Computed tomography (CT) scans of the chest (Fig 2) , abdomen, and pelvis confirmed the presence of tamponade and effusion plus the presence of ascites and small retroperitoneal adenopathy (unchanged since 1989) but no splenomegaly. Pericardiocentesis yielded 800 ml of exudative fluid with a lactic dehydrogenase value of 14,000 IU/L and cytologically contained cells characteristic of large cell immunoblastic lymphoma (Fig 3) . Subsequent bacterial, viral, fungal, and mycobacterial stains and cultures were negative. Additional staging studies including bilateral bone marrow aspirates and biopsies, CT scan of the head, and lumbar puncture were negative for systemic lymphoma.
The patient was treated with cyclophosphamide, 750 mg/m2 intravenously on day 1; mitroxantrone (Novantrone) 8 mg/mr2 intravenously on day 1; etoposide 75 mg/m2 intravenously on day 1; vincristine, 2 mg intravenously on day 1; and prednisone, 50 mg/m2 orally on days 1 through 7. Neutrophil counts were augmented with granulocyte colony-stimulating factor, 5 gg/kg, subcutaneously on days 2 through 14. Within days after the first cycle of therapy, the patient's symptoms had resolved. A repeat chest roentgenogram and echocardiogram one week later showed complete resolution of pleural and pericardial effusion. A total of six cycles of chemotherapy were given over a 6-month period. Detailed restaging, including CT scans and repeat bone marrow assessment, clinically confirmed that the patient was in complete remission. The patient died 12 months after his initial diagnosis of immunoblastic lymphoma but without evidence of recurrent tumor. An autopsy was not performed.
DISCUSSION
This article considers the case of a homosexual man with KS who presented with signs and symptoms of congestive heart failure. During initial evaluation, a cardiac echocardiogram demonstrated a large pericardial effusion with tamponade. Pericardiocentesis yielded a diagnosis of immunoblastic lymphoma. The tumor was not found in re- gestive heart failure without obvious cause.14152325
A collection of imaging studies were performed on these patients, but the results rarely prompted a concern for cardiac lymphoma. Chest radiographs were nonspecific; an enlarged cardiac silhouette was noted in 7 patients and pleural effusion in 5. 10, 14, 16, 23, 25, 26 The delay in considering NHL in the differential diagnosis of an AIDS patient with shortness of breath and effusions is understandable when one considers the rare finding of cardiac lymphoma even in patients with enlarged cardiac silhouettes. In a retrospective study by Reynolds et al,28 of 14 AIDS patients presenting with large pericardial effusions 8 had evidence of mycobacterial disease. Cardiac lymphoma was found in one patient, but four others had KS. This and other studies serve to emphasize the malignancy most associated with cardiac disease in HIV-infected patients is KS. Like NHL, KS is most likely to be widespread by the time it is found to involve the heart.29 30 Autopsy studies have shown that KS most commonly invades the epicardium and, more rarely, the myocardium or pericardium.20 '31 In contrast to NHL, KS of the heart often is asymptomatic. Ironically, the presence of disseminated KS does not ensure that neoplastic cardiac complications are due to KS. Like the report of our patient, Guarner et al'4 described two homosexuals with widely scattered KS who at autopsy were found to have cardiac NHL.
In non-AIDS-related cardiac NHL, Chow et al'9 found that gallium scanning was useful in suggesting the presence of cardiac tumors. Although we can make no inference regarding the sensitivity or specificity of this technique, the three patients with AIDS-related cardiac lymphoma who underwent this procedure had intense myocardial uptake.""5'22 Echocardiograms and CT scans of the chest were abnormal in all patients in whom they were obtained, with some instances demonstrating large pericardial effusions and others showing frank mass lesions. In a single case report, magnetic resonance imaging of the chest proved useful in delineating the extrapericardial extent of tumor. 16 Cardiac tamponade is a distinctly unusual feature of '25,26,32 As was true in our patient's case, the reported diagnosis of the disease was made during life either by cytologic examination of pericardial or pleural fluid or by endomyocardial biopsy, allowing for initiation of chemotherapy (Table 2) . After diagnosis, survival is generally less than 6 months. The good response to chemotherapy seen in our patient, however, is not unique. Kelsey et a126 treated a patient with cyclophosphamide, doxorubicin, vincristine, and pred- 
